1.
In-Depth In Silico Investigation Of Gitalin And Glaziovine As Possible VEGFR-2 Kinase Inhibitors For The Treatment Of Cancer. Journal of Pharmaceutical Negative Results [Internet]. 2022 Dec. 31 [cited 2026 Jun. 27];:6523-31. Available from: https://www.pnrjournal.com/index.php/home/article/view/10648